{"entity":{"id":"andrei-iagaru","kind":"person","name":"Andrei Iagaru","aka":[],"tldr":"A Stanford nuclear medicine professor who led the division for a decade and has published widely on new PET tracers, from FAPI scans of fibrosis-related proteins to whole-body PET scanners that image the entire body at once.","summary":"Andrei Iagaru joined Stanford in 2007 and served as Chief of the Division of Nuclear Medicine and Molecular Imaging from 2016 (co-chief from 2011); Stanford's faculty listing as of September 2026 names Erin Grady as interim division chief, indicating a leadership transition, while Iagaru continues as Professor of Radiology. He has authored or co-authored more than 200 peer-reviewed papers spanning 68Ga-PSMA-11 and 18F-DCFPyL PET for prostate cancer, gastrin-releasing peptide receptor (GRPR) imaging, and fibroblast activation protein inhibitor (FAPI) PET.\n\nHe has been a prominent voice in the debate over whether FAPI PET will replace FDG PET in oncologic staging, arguing for a complementary rather than replacement role, and is active in total-body and long-axial-field-of-view PET research and international PET/MRI consensus guideline efforts with EANM, SNMMI and ISMRM.","asOf":"2026-09-22","links":[{"label":"Stanford Profiles","url":"https://cap.stanford.edu/profiles/frdActionServlet?choiceId=printerprofile&profileversion=full&profileId=8156"},{"label":"Stanford Nuclear Medicine faculty page","url":"https://med.stanford.edu/nuclearmedicine/people/faculty.html"}],"tags":["PSMA","FAPI","total-body PET","clinician"],"related":["fapi-pet","ga68-psma-11","pet-mri","f-18","ga-68"],"indications":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor of Radiology (Nuclear Medicine), Stanford University Medical Center (formerly Chief of the Division of Nuclear Medicine and Molecular Imaging, 2016-2026; Stanford's faculty page as of September 2026 lists Erin Grady, MD, as Interim Division Chief)","specialisms":["FAPI PET","total-body and long-axial-field-of-view PET","PSMA PET"],"profiles":[{"label":"Stanford Profiles CV","url":"https://cap.stanford.edu/profiles/viewCV?facultyId=8156&name=Andrei_Iagaru"},{"label":"Stanford Nuclear Medicine faculty page","url":"https://med.stanford.edu/nuclearmedicine/people/faculty.html"},{"label":"Google Scholar","url":"https://scholar.google.com/citations?user=8RwEbvgAAAAJ&hl=en"}],"papers":[{"title":"Will FAPI PET/CT Replace FDG PET/CT in the Next Decade?-Counterpoint: No, not so fast!","journal":"American Journal of Roentgenology","year":2020,"url":"https://pubmed.ncbi.nlm.nih.gov/33356420/"},{"title":"Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer","journal":"Radiology","year":2018,"url":"https://pubs.rsna.org/doi/10.1148/radiol.2018172232"},{"title":"International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology","journal":"European Journal of Nuclear Medicine and Molecular Imaging","year":2023}]},"route":"/people/andrei-iagaru/","neighbours":{"technology":[{"id":"fapi-pet","kind":"technology","name":"FAPI PET","route":"/technologies/fapi-pet/"},{"id":"pet-mri","kind":"technology","name":"PET/MRI","route":"/technologies/pet-mri/"}],"drug":[{"id":"ga68-psma-11","kind":"drug","name":"Gallium-68 gozetotide (PSMA-11)","route":"/drugs/ga68-psma-11/"}],"isotope":[{"id":"f-18","kind":"isotope","name":"Fluorine-18","route":"/isotopes/f-18/"},{"id":"ga-68","kind":"isotope","name":"Gallium-68","route":"/isotopes/ga-68/"}]}}